Role of homocysteine in the treatment of Parkinson's disease. - Wikidata - awgldk - TriplyDB

Role of homocysteine in the treatment of Parkinson's disease.

Role of homocysteine in the treatment of Parkinson's disease.

http://www.wikidata.org/entity/Q37174063

about

Associations between B Vitamins and Parkinson's Disease New small molecules for the treatment of Parkinson's disease.Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results.Complexity of dopamine metabolism.Homocysteine Level and Mechanisms of Injury in Parkinson's Disease as Related to MTHFR, MTR, and MTHFD1 Genes Polymorphisms and L-Dopa Treatment.Motor complications, levodopa metabolism and progression of Parkinson's disease.Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson's disease.Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo).Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference Possible treatment concepts for the levodopa-related hyperhomocysteinemia.Long-term levodopa/carbidopa intestinal gel in advanced Parkinson's disease.Nutritional habits, risk, and progression of Parkinson disease.Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.

P2860

Q26783632-FFE1F20B-6F0C-454E-BB57-C9A74A011D61 Q33636631-D9B159E6-747B-4661-84DC-0B2A6499136D Q33695388-90CBD953-A335-4886-980A-A34C56A5109D Q36866618-00F4B073-5257-47E9-884C-870FF4E6CC66 Q36958208-6A8668BC-6137-41FD-9B86-258501A75F8C Q37583408-B554FF0E-FEFF-41BA-B6CC-04E25A8D7BA0 Q37863681-DFDE8FCC-4C77-4C69-8D10-FD082EFA8981 Q38112217-BACB9743-7017-400C-AD9E-386423F2E70A Q42427666-8B6F1E70-AE28-420D-AB73-E5845DDD890D Q42642958-82744384-F5C5-4A02-A471-F43C28090BE8 Q42952317-C043F36C-C59A-436F-952D-7C58691408EA Q45246047-688FB6E6-64D0-4602-B498-79C910005365 Q48024631-03FD8090-BCAD-4EBC-8D5F-CB144F04D5F1 Q50664318-47411DDA-32CE-49F6-A034-7309765DC877

P2860

Role of homocysteine in the treatment of Parkinson's disease.

http://www.wikidata.org/entity/Q37174063

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of homocysteine in the treatment of Parkinson's disease.

@en

Role of homocysteine in the treatment of Parkinson's disease.

@nl

type

label

Role of homocysteine in the treatment of Parkinson's disease.

@en

Role of homocysteine in the treatment of Parkinson's disease.

@nl

prefLabel

Role of homocysteine in the treatment of Parkinson's disease.

@en

Role of homocysteine in the treatment of Parkinson's disease.

@nl

P1433

Q37174063-AA73B845-910D-4787-87E1-BB46C281C600

P1476

Q37174063-10110C74-4FDC-480B-92DF-BB528D3AAF76

P2860

Q37174063-0157C700-849D-4E35-84EA-85C26235FCAD

Q37174063-0E4BCA4B-0973-484C-B9D2-1EEDEAEEF6EB

Q37174063-0F95925A-4D2D-40A5-B9EA-06F826CF9835

Q37174063-176D2600-1472-42BD-81DB-28C106EE1688

Q37174063-1C6DF5F7-6AB0-40C4-8FAB-16BCDAAC2D5C

Q37174063-207163D1-C42C-45AB-9071-1B05F1BE6AA0

Q37174063-21508689-95F6-4E41-88AE-D03694446376

Q37174063-239C1469-5263-428C-BF82-5CBABD43A802

Q37174063-286723AA-E730-4356-BBFE-75AA67D43BF8

Q37174063-2B503A11-3422-4C7B-BC85-D0311BEE1275

P304

Q37174063-59C087E5-967A-4949-8B60-40E64A92CF7B

P31

Q37174063-34612EFE-A427-4DE3-9346-CB887EB2D799

P356

Q37174063-12B1BC56-63E2-4317-B97F-5B4570B11BD9

P4011

Q37174063-A83772A0-2B45-4307-AFF7-39D595D3996B

P407

Q37174063-BF58675A-5C50-439A-86C7-73B3C02BC33B

P433

Q37174063-BD40A667-5881-48F3-A8A2-BFA3D5E75977

P478

Q37174063-30747C69-8483-4E7E-8459-8AFDBAAAD33F

P50

Q37174063-A59299DC-FCFE-42E8-98CE-2E6BE6EEDC95

P577

Q37174063-D2E75F9C-99B2-4A62-BA65-D1FB084DF78D

P698

Q37174063-41A24492-453C-4158-A454-86E989B72A06

P921

Q37174063-ECD12DF7-55F8-4DB1-AFB3-FAAB65867D19

P356

14737175.8.6.957

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

Role of homocysteine in the treatment of Parkinson's disease.

@en

P2860

The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats

Activation of catechol-O-methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons

Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson's disease.

Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis.

Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?

Hyperhomocysteinemia in chronic alcoholism: relations to folic acid and vitamins B(6) and B(12) status.

Homocysteine, Alzheimer's disease, and cognitive function.

Levodopa and the progression of Parkinson's disease.

Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis.

N-methylation underlying Parkinson's disease.

P304

957-967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737175.8.6.957

http://www.w3.org/2001/XMLSchema#string

P4011

73ea699a070508d430f760182d52724937d1145e

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18505360

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease